Analyst Ratings for TransMedics Group (TMDX )
TMDX Rating Summary
TMDX Price Target Summary
- Highest: $190.00 (TD Cowen)
- Lowest: $80.00 (Stifel)
- Average: $134.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$134.30 (+81.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$134.30 (+81.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/6/2026 | Oppenheimer | Suraj Kalia | Downgrade | Perform (Outperform) |
N/A (N/A) |
94.93 (73.83) |
-22.23% | Details |
| 10/23/2025 | Needham » Updated 5/6/2026 |
Mike Matson | Upgrade | Buy (Hold) |
142.00 (174.00) |
119.54 (73.83) |
-38.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
